» Articles » PMID: 34105887

Global, Regional and National Incidence, Mortality and Disability-adjusted Life-years of Skin Cancers and Trend Analysis from 1990 to 2019: An Analysis of the Global Burden of Disease Study 2019

Overview
Journal Cancer Med
Specialty Oncology
Date 2021 Jun 9
PMID 34105887
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Information about global and local epidemiology and trends of skin cancers is limited, which increases the difficulty of cutaneous cancer control.

Methods: To estimate the global spatial patterns and temporal trends of skin cancer burden. Based on the GBD 2019, we collected and analyzed numbers and age-standardized rates (ASR) of skin cancer incidence, disability-adjusted life years (DALYs) and mortality (ASIR, ASDR, and ASMR) in 204 countries from 1990 through 2019 were estimated by age, sex, subtype (malignant skin melanoma [MSM], squamous-cell carcinoma [SCC], and basal-cell carcinoma [BCC]), Socio-demographic Index (SDI), region, and country. Temporal trends in ASR were also analyzed using estimated annual percentage change.

Results: Globally, in 2019, there were 4.0 million BCC, 2.4 million SCC, and 0.3 million MSM. There were approximately 62.8 thousand deaths and 1.7 million DALYs due to MSM, and 56.1 thousand deaths and 1.2 million DALYs were attributed to SCC, respectively. The men had higher ASR of skin cancer burden than women. The age-specific rates of global skin cancer burden were higher in the older adults, increasing trends observed from 55 years old. Geographically, the numbers and ASR of skin cancers varied greatly across countries, with the largest burden of ASIR in high SDI regions. However, an unexpected increase was observed in some regions from 1990 to 2019, such as East Asia, and Sub-Saharan Africa. Although there was a slight decrease of the ASMR and ASDR, the global ASIR of MSM dramatically increased, 1990-2019. Also, there was a remarkable increase in ASR of BCC and SCC burden.

Conclusions: Skin cancer remains a major global public health threat. Reducing morbidity and mortality strategies such as primary and secondary prevention should be reconsidered, especially in the most prevalent and unexpected increased regions, especially for those areas with the greatest proportions of their population over age 55.

Citing Articles

Trend of skin cancer mortality and years of life lost in China from 2013 to 2021.

Li J, Zeng J, Yang Y, Huang B Front Public Health. 2025; 13:1522790.

PMID: 40013033 PMC: 11861555. DOI: 10.3389/fpubh.2025.1522790.


Global, regional, national prevalence, mortality, and disability-adjusted life-years of cutaneous squamous cell carcinoma and trend analysis from 1990 to 2021 and prediction to 2045.

Liu C, Liu X, Cao P, Li X, Xin H, Zhu S Front Oncol. 2025; 15:1523169.

PMID: 39980558 PMC: 11839636. DOI: 10.3389/fonc.2025.1523169.


Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.

Eigentler T, Thomas I, Samoylenko I, Erdmann M, Heinzerling L, Ochsenreither S J Immunother Cancer. 2025; 13(2).

PMID: 39904560 PMC: 11795518. DOI: 10.1136/jitc-2024-009352.


Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021.

Zhang C, Chen L, Xiu Y, Zhang H, Zhang Y, Ying W Front Oncol. 2025; 14:1518567.

PMID: 39902130 PMC: 11788179. DOI: 10.3389/fonc.2024.1518567.


Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea.

Jung J, Kim D, Kim Y, Moon I, Lee W, Chang S Sci Rep. 2025; 15(1):3541.

PMID: 39875452 PMC: 11775261. DOI: 10.1038/s41598-025-87838-3.


References
1.
Moslehi R, Zeinomar N, Boscoe F . Incidence of cutaneous malignant melanoma in Iranian provinces and American states matched on ultraviolet radiation exposure: an ecologic study. Environ Pollut. 2017; 234:699-706. PMC: 5921862. DOI: 10.1016/j.envpol.2017.11.099. View

2.
Halder R, Ara C . Skin cancer and photoaging in ethnic skin. Dermatol Clin. 2004; 21(4):725-32, x. DOI: 10.1016/s0733-8635(03)00085-8. View

3.
Brinton L, Figueroa J, Awuah B, Yarney J, Wiafe S, Wood S . Breast cancer in Sub-Saharan Africa: opportunities for prevention. Breast Cancer Res Treat. 2014; 144(3):467-78. PMC: 4023680. DOI: 10.1007/s10549-014-2868-z. View

4.
Morgan F, Duran J, Fraile B, Karia P, Lin J, Ott P . A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013. J Am Acad Dermatol. 2018; 79(5):921-928. DOI: 10.1016/j.jaad.2018.06.045. View

5.
Martin A, Lin M, Granka J, Myrick J, Liu X, Sockell A . An Unexpectedly Complex Architecture for Skin Pigmentation in Africans. Cell. 2017; 171(6):1340-1353.e14. PMC: 5884124. DOI: 10.1016/j.cell.2017.11.015. View